EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study

Irit Ben-Aharon iD, Tal Goshen-Lago, Alberto Puccini, Maria Alsina, Dirk Arnold, Hanneke van Laarhoven, Anneli Elme, Tineke Buffart, Nina Fokter-Dovnik, Tomas Sokop, Radka Obermanova, Florian Lordick iD und 4 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyaf350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Irit Ben-Aharon und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel. Hauptthemen laut MEDLINE: Fertility Preservation, Gastrointestinal Neoplasms, Oncologists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The rising incidence of early-onset gastrointestinal (GI) cancer has made the impact of treatments on fertility of high significance. While there is abundant evidence on oncofertility outcomes in breast cancer and hematological malignancies, data regarding these perspectives in GI cancers is lacking. We sought to evaluate current practices of fertility preservation (FP) among GI oncologists across Europe.

Methods

A cross-sectional survey was distributed through the Gastrointestinal Tract Cancer Group (GITCG) of the EORTC network and affiliated cooperative groups and cancer centers using a 10-item electronic survey regarding oncofertility practices. The target population was oncologists who routinely treat GI cancers. A statistical analysis was performed based on country, patient volume, and tumor type.

Results

Two hundred and twenty-six GI oncologists from 27 countries completed the survey, the majority from high volume cancer centers. Fifty seven percent of the participating oncologists routinely discuss the impact of treatment on fertility in any patient <40 years, while 36% discuss this only in the curative setting. Fifty-nine percent refer female patients to standard FP options (embryo/oocyte preservation), while 24% chose to refer to ovarian cryopreservation. Of note, 17% indicated they would not refer a curative patient for FP at all due to time or resource issues. Sixty five percent routinely refer male patients to sperm preservation. Use of Gonadotropin Releasing Hormone analogues (GnRHa) in CRC patients is recommended by 34% of oncologists. In the setting of pelvic radiation, 65% refer a female patient for ovarian transposition before pelvic irradiation; 32% would consider uterine transposition. Sixty one percent would consider a nonradiation protocol as perioperative chemotherapy as a valid option for young female patients. We observed heterogeneity upon country but not upon physician gender.

Conclusion

Our study indicates a substantial diversity in current practices in Europe with regard to FP in young cancer patients with GI malignancies, which is not always aligned with current guidelines. There is a need to disseminate and educate GI oncologists on oncofertility perspectives and contemporary data. Additionally, there is a need to establish evidence on the utility of fertility preservation options for patients with GI cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationGastrointestinal NeoplasmsOncologistsHumansFemaleEuropeMaleCross-Sectional StudiesAdultSurveys and QuestionnairesPractice Patterns, Physicians'Middle Aged

Stichwörter der Autor:innen

European oncology practicesfertility preservationgastrointestinal canceroncofertilityyoung adult cancer patients

Autor:innen und Institutionen

  • Division of Oncology, Rambam Health Care Campus, Haifa 31096, Israel.
  • Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 3200003, Israel.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan 20090, Italy.
  • IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Humanitas Cancer Center, Rozzano, Milan 20089, Italy.
  • Medical Oncology Department, Hospital Universitario de Navarra, Pamplona 31008, Spain.
  • Asklepios Tumor Center Hamburg and AK Altona, Hamburg 22763, Germany.

ORCID-Profile: Irit Ben-Aharon, Florian Lordick, Elena Elez, Julien Taieb

Zitieren

APA

Ben-Aharon, I., Goshen-Lago, T., Puccini, A., Alsina, M., Arnold, D., van Laarhoven, H., Elme, A., Buffart, T., Fokter-Dovnik, N., Sokop, T., Obermanova, R., Lordick, F., Papamichael, D., Sclafani, F., Elez, E., & Taieb, J. (2025). Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study. The Oncologist. https://doi.org/10.1093/oncolo/oyaf350

Vancouver

Ben-Aharon I, Goshen-Lago T, Puccini A, Alsina M, Arnold D, van Laarhoven H, et al. Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study. The Oncologist. 2025. doi:10.1093/oncolo/oyaf350

BibTeX
@article{BenAharon2025,
  author = {Ben-Aharon, Irit and Goshen-Lago, Tal and Puccini, Alberto and Alsina, Maria and Arnold, Dirk and van Laarhoven, Hanneke and Elme, Anneli and Buffart, Tineke and Fokter-Dovnik, Nina and Sokop, Tomas and Obermanova, Radka and Lordick, Florian and Papamichael, Demetris and Sclafani, Francesco and Elez, Elena and Taieb, Julien},
  title = {Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyaf350}
}
Kostenlos starten →